Although in the analysis with outcomes from PGC, GLP1RA use was associated with an increased risk of AN, and in the analysis with outcomes from FinnGen, GLP1RA use was associated with a reduced risk of ADHD, ASD, and PTSD, the meta-analysis failed to reach statistical significance.
← all excerpts
Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study.
1
—
—